sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride

C84H82ClN22NaO13 — CID 167655396

IUPACsodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride
SMILESCCOC(=O)c1cc(C)nn1-c1ncc2ccccc2n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(=O)C(N)=O)n(-c2ncc3ccccc3n2)n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(O)C(N)=O)n(-c2ncc3ccccc3n2)n1.Cc1cc(C(=O)O)n(-c2ncc3ccccc3n2)n1.Cl.NC(=O)C(O)C(N)Cc1ccccc1.[Na+].[OH-]
InChIInChI=1S/C23H22N6O3.C23H20N6O3.C15H14N4O2.C13H10N4O2.C10H14N2O2.ClH.Na.H2O/c2*1-14-11-19(29(28-14)23-25-13-16-9-5-6-10-17(16)27-23)22(32)26-18(20(30)21(24)31)12-15-7-3-2-4-8-15;1-3-21-14(20)13-8-10(2)18-19(13)15-16-9-11-6-4-5-7-12(11)17-15;1-8-6-11(12(18)19)17(16-8)13-14-7-9-4-2-3-5-10(9)15-13;11-8(9(13)10(12)14)6-7-4-2-1-3-5-7;;;/h2-11,13,18,20,30H,12H2,1H3,(H2,24,31)(H,26,32);2-11,13,18H,12H2,1H3,(H2,24,31)(H,26,32);4-9H,3H2,1-2H3;2-7H,1H3,(H,18,19);1-5,8-9,13H,6,11H2,(H2,12,14);1H;;1H2/q;;;;;;+1;/p-1
InChIKeyHBHLKFFUHDDJKX-UHFFFAOYSA-M
MW1666.16 g/mol
LogP3.60
Rot. Bonds23

About sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride

sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride (PubChem CID 167655396) has the molecular formula C84H82ClN22NaO13 and a molecular weight of 1666.16 g/mol. Its IUPAC name is sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride.

Molecular Properties

Compound Namesodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride
PubChem CID167655396
Molecular FormulaC84H82ClN22NaO13
Molecular Weight1666.16 g/mol
Exact Mass1664.60
IUPAC Namesodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride
SMILESCCOC(=O)c1cc(C)nn1-c1ncc2ccccc2n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(=O)C(N)=O)n(-c2ncc3ccccc3n2)n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(O)C(N)=O)n(-c2ncc3ccccc3n2)n1.Cc1cc(C(=O)O)n(-c2ncc3ccccc3n2)n1.Cl.NC(=O)C(O)C(N)Cc1ccccc1.[Na+].[OH-]
InChIInChI=1S/C23H22N6O3.C23H20N6O3.C15H14N4O2.C13H10N4O2.C10H14N2O2.ClH.Na.H2O/c2*1-14-11-19(29(28-14)23-25-13-16-9-5-6-10-17(16)27-23)22(32)26-18(20(30)21(24)31)12-15-7-3-2-4-8-15;1-3-21-14(20)13-8-10(2)18-19(13)15-16-9-11-6-4-5-7-12(11)17-15;1-8-6-11(12(18)19)17(16-8)13-14-7-9-4-2-3-5-10(9)15-13;11-8(9(13)10(12)14)6-7-4-2-1-3-5-7;;;/h2-11,13,18,20,30H,12H2,1H3,(H2,24,31)(H,26,32);2-11,13,18H,12H2,1H3,(H2,24,31)(H,26,32);4-9H,3H2,1-2H3;2-7H,1H3,(H,18,19);1-5,8-9,13H,6,11H2,(H2,12,14);1H;;1H2/q;;;;;;+1;/p-1
InChIKeyHBHLKFFUHDDJKX-UHFFFAOYSA-M
XLogP3.60
TPSA539.02 Ų
H-Bond Donors9
H-Bond Acceptors29
Rotatable Bonds23
Heavy Atoms121
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001666.16
LogP ≤ 53.60
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride?
The IUPAC name of sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride (CID 167655396) is sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride.
What is the SMILES notation for sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride?
The canonical SMILES for sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride is CCOC(=O)c1cc(C)nn1-c1ncc2ccccc2n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(=O)C(N)=O)n(-c2ncc3ccccc3n2)n1.Cc1cc(C(=O)NC(Cc2ccccc2)C(O)C(N)=O)n(-c2ncc3ccccc3n2)n1.Cc1cc(C(=O)O)n(-c2ncc3ccccc3n2)n1.Cl.NC(=O)C(O)C(N)Cc1ccccc1.[Na+].[OH-].
What is the InChIKey of sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride?
The InChIKey is HBHLKFFUHDDJKX-UHFFFAOYSA-M. The full InChI is InChI=1S/C23H22N6O3.C23H20N6O3.C15H14N4O2.C13H10N4O2.C10H14N2O2.ClH.Na.H2O/c2*1-14-11-19(29(28-14)23-25-13-16-9-5-6-10-17(16)27-23)22(32)26-18(20(30)21(24)31)12-15-7-3-2-4-8-15;1-3-21-14(20)13-8-10(2)18-19(13)15-16-9-11-6-4-5-7-12(11)17-15;1-8-6-11(12(18)19)17(16-8)13-14-7-9-4-2-3-5-10(9)15-13;11-8(9(13)10(12)14)6-7-4-2-1-3-5-7;;;/h2-11,13,18,20,30H,12H2,1H3,(H2,24,31)(H,26,32);2-11,13,18H,12H2,1H3,(H2,24,31)(H,26,32);4-9H,3H2,1-2H3;2-7H,1H3,(H,18,19);1-5,8-9,13H,6,11H2,(H2,12,14);1H;;1H2/q;;;;;;+1;/p-1.
What are the key properties of sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride?
sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride has a molecular weight of 1666.16 g/mol, XLogP of 3.60, 23 rotatable bonds, 9 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-methyl-2-quinazolin-2-ylpyrazole-3-carboxamide;3-amino-2-hydroxy-4-phenylbutanamide;ethyl 5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylate;5-methyl-2-quinazolin-2-ylpyrazole-3-carboxylic acid;hydroxide;hydrochloride is sourced from PubChem (CID 167655396), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).